FIELD: pharmacology.
SUBSTANCE: invention relates to compounds of formula (I): , as well as to pharmaceutically acceptable salts, pharmaceutical compositions and application thereof.
EFFECT: new compounds that are CRTH2 receptor antagonists have been obtained that can be useful for respiratory diseases treatment or prevention.
20 cl, 2 tbl, 37 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII | 2016 |
|
RU2729609C2 |
NOVEL PIRIDAZONES AND TRIAZINONES FOR TREATMENT AND PREVENTING OF HEPATITIS B VIRUS INFECTION | 2015 |
|
RU2664329C1 |
3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-c] PYRROLES AS GLUCOKINASE ACTIVATORS | 2011 |
|
RU2603191C2 |
ISOQUINOLINONE DERIVATIVES USEFUL IN TREATING CANCER | 2015 |
|
RU2690853C2 |
PIPERAZINO[1,2-A]INDOLE-1-ONES AND [1,4] DIAZEPTINO[1,2-A]INDOLE-1-ONE | 2014 |
|
RU2628126C2 |
DERIVATIVE 6-CARBONITRILE DIPYRIDOPYRROLES AND APPLICATION THEREOF IN CANCER TREATMENT | 2010 |
|
RU2575635C2 |
COMT INHIBITORS | 2013 |
|
RU2642779C2 |
AZAINDOLES AS GLUCOKINASE ACTIVATORS | 2010 |
|
RU2593369C2 |
BRUTON'S TYROSINE KINASE INHIBITORS | 2014 |
|
RU2648236C2 |
HYBRID DERIVATIVES OF (1H-1,2,4) TRIAZOLE AND SULPHUR-CONTAINING HETEROCYCLES: DERIVATIVES OF THIAZOLIDINE-2,4-DIONE, THIOMORPHOLINE-3-ONE, AND 1,4-THIAZEPAN-3-ONE, EXHIBITING ANTIMICROBIAL ACTIVITY | 2020 |
|
RU2771027C1 |
Authors
Dates
2017-08-14—Published
2012-12-10—Filed